Journal
/
/
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Journal JoVE
Médecine
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
DOI:

19:44 min

May 30, 2012

, , ,

Chapitres

  • 00:05Titre
  • 02:49Time-lapse Microscopy
  • 04:34Water Soluble Tetrazolium Salt (WST-1) Assay for Cell Viability
  • 07:05Mitochondrial Isolation
  • 08:34Amplex Red Assay for ROS Generation
  • 09:30Results: Selective Induction of Apoptosis in MCF7 and SH-SY5Y Cells by JCTH-4 and Enhancement of Activity by TAM
  • 18:29Conclusion

Summary

Traduction automatique

We have synthesized a novel analogue of pancratistatin with comparable anti-cancer activity as native pancratistatin; interestingly, combinatory treatment with tamoxifen yielded a drastic enhancement in apoptotic and autophagic induction by mitochondrial targeting with minimal effect on noncancerous fibroblasts. Thus, JCTH-4 in combination with tamoxifen could provide a safe anti-cancer therapy.

Vidéos Connexes

Read Article